Tag: pharmaceuticals
-
Tissue Regeneration Start-Up Gains $33M in Early Funds
A new enterprise founded by researchers at Stanford University aims to discover and develop drugs that repair and regenerate tissue from stem cells.
-
Biotech Group Withholds Support for Germline Trial Report
A biotechnology industry association in the U.S. says its members are not ready to support recommendations in a new report permitting future clinical studies of genome editing for inheritable disease-causing traits.
-
Cancer Drug Shown to Improve Survival Time in Dogs
A drug to treat a deadly cancer in dogs was shown in a clinical trial to extend the survival time of canine patients by 6 months or more, with potential applications in humans.
-
Biotechs License Solid Tumor Therapy in $2.1B Deal
Biotechnology enterprise Immunomedics Inc. is licensing its enhanced antibody-based treatment for solid tumor cancers to Seattle Genetics, a developer of similar cancer drugs.
-
Low-Dose Multidrug Shown Effective in Hypertension Trial
A small-scale clinical trial shows a combination of four current drugs to treat hypertension, or high blood pressure, formulated in low doses, reduces blood pressure to normal levels in four weeks.
-
DNA Tags Speed Nanoparticle Gene Therapy Discovery
Biomedical engineers developed a technique with unique DNA identifiers that makes possible faster screening of gene therapies delivered with nanoscale particles.
-
Protein Drug Discovery Company Launches, Gains $50M
A biotechnology enterprise founded by faculty at Scripps Research Institute plans to discover new therapies based on complex interactions with human proteins.
-
Asthma Drug Tested as Alcoholism Treatment
Results from a small-scale clinical trial show an established drug to treat asthma and other inflammatory conditions has promise as a treatment for alcohol dependence.
-
Grid Computing Harnessed for Childhood Cancer Research
An international consortium is seeking crowdsourced computing power to screen drug candidates for treating a number of cancers affecting children.
-
Novo Nordisk to Open Oxford Diabetes Research Center
The pharmaceutical company Novo Nordisk will build a research center to study type 2 diabetes on the campus of University of Oxford in the U.K.